Technology
Health
Pharmaceutical

Menlo Therapeutics

$3.42
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.15 (4.59%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell MNLO and other stocks, options, ETFs, and crypto commission-free!

About MNLO

Menlo Therapeutics Inc. Common Stock, also called Menlo Therapeutics, is focused on the development and commercialization of serlopitant for the treatment of pruritus, or itch, associated with dermatologic conditions such as atopic dermatitis, psoriasis and prurigo nodularis. Read More The company was founded in October, 2011 and is headquartered in Redwood City, CA.

Employees
43
Headquarters
Redwood City, California
Founded
2011
Market Cap
81.92M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
34.00K
High Today
$3.45
Low Today
$3.26
Open Price
$3.28
Volume
29.93K
52 Week High
$12.00
52 Week Low
$2.69

Collections

Technology
Health
Pharmaceutical
Therapy
Biopharmaceutical
2018 IPO
US
North America

MNLO Earnings

-$0.89
-$0.78
-$0.67
-$0.56
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Expected Nov 6, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.